Finance

Beta
Lists
CLPBF:OTCMKTS
Coloplast A/S
$57.64
+0.62%
(+0.36) 1D
Jun 3, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLPBF...
Open
$57.62
High
$59.86
Low
$57.62
Mkt. cap
79.69B
Avg. vol.
2.48K
Volume
1.16K
52-wk high
$100.00
52-wk low
$57.28
Beta
0.85
Shares outstanding
210.20M
No. of employees
17K
Open
$57.62
High
$59.86
Low
$57.62
Mkt. cap
79.69B
Avg. vol.
2.48K
Volume
1.16K
52-wk high
$100.00
52-wk low
$57.28
Beta
0.85
Shares outstanding
210.20M
No. of employees
17K
News stories
From sources across the web
Profile
Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care. Wikipedia
About Coloplast A/S
CEO-
Employees17.1K
Founded1957
HeadquartersHumlebaek, Capital Region of Denmark, Denmark
SectorMedical device
Websitecoloplast.com
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.96B
6.96B
7.04B
7.08B
Cost of goods sold
2.25B
2.20B
2.31B
2.37B
Cost of revenue
2.25B
2.20B
2.31B
2.37B
Research and development expenses
239.00M
249.00M
247.00M
254.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.58B
2.62B
2.64B
2.67B
Operating expense
2.79B
2.79B
2.88B
2.90B
Total operating expenses
5.04B
4.99B
5.19B
5.26B
Operating income
1.92B
1.97B
1.85B
1.82B
Other non operating income
-75.00M
-6.00M
42.00M
-188.00M
EBT including unusual items
1.34B
1.56B
1.79B
-1.24B
EBT excluding unusual items
1.42B
1.81B
1.83B
1.78B
Income tax expense
537.00M
680.00M
394.00M
-273.00M
Effective tax rate
40.01%
43.73%
22.00%
21.95%
Other operating expenses
-27.00M
-80.00M
-6.00M
-23.00M
Net income
805.00M
875.00M
1.40B
-971.00M
Net profit margin
11.57%
12.57%
19.84%
-13.71%
Earnings per share
4.93
4.67
-
6.16
Interest and investment income
-
22.00M
32.00M
149.00M
Interest expense
-415.00M
-152.00M
-164.00M
-
Net interest expenses
-415.00M
-130.00M
-132.00M
149.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.26B
2.20B
2.20B
2.17B
Gain or loss from assets sale
46.00M
2.00M
-
1.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer